Cleveland BioLabs, Inc. is a biopharmaceutical company. The company has market cap of $16.70 million. The Firm is engaged in developing approaches to activate the immune system and address serious medical needs. It currently has negative earnings. The Company’s platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology.
The Chairman of the Board of Idt Corp and company’s insider Howard Jonas paid for 728,332 shares of the New Jersey-based company estimated based on $13.7 for every share . The shares have a value of $10.00 million U.S. Dollars. Having been a very large stock acquisition at Idt Corp, the probability that it remains unnoticed for long was obviously very low. Howard Jonas today holds 2.75 million shares which make up roughly 12.17% of the New Jersey-Company’s market cap.
Investors sentiment increased to 1.45 in Q4 2016. Its up 0.09, from 1.36 in 2016Q3. It is positive, as 14 investors sold IDT Corporation shares while 28 reduced holdings. 23 funds opened positions while 38 raised stakes. 12.59 million shares or 0.48% less from 12.65 million shares in 2016Q3 were reported. Chicago Equity Prtn Ltd Liability Co has 214,415 shares for 0.11% of their portfolio. Credit Suisse Ag reported 16,066 shares or 0% of all its holdings. Citadel Advsr Ltd Limited Liability Company reported 11,022 shares stake. Bridgeway Cap Management owns 0.01% invested in IDT Corporation (NYSE:IDT) for 25,817 shares. Acadian Asset Limited stated it has 0.07% of its portfolio in IDT Corporation (NYSE:IDT). Eagle Glob Advsrs Ltd Liability Corporation has 26,880 shares. Tfs Limited reported 20,778 shares stake. Prudential Fincl holds 24,064 shares or 0% of its portfolio. Blackrock Institutional Na has invested 0% in IDT Corporation (NYSE:IDT). Blackrock Limited stated it has 0% in IDT Corporation (NYSE:IDT). Bogle Management Lp De holds 0.1% or 77,722 shares. Nationwide Fund Advisors invested in 51,672 shares. Prelude Mgmt Limited Liability owns 1,000 shares. Renaissance Tech Ltd reported 1.38 million shares. First L P invested in 19,276 shares.
IDT Corporation is a holding company with activities primarily in the telecommunications and payment industries. The company has market cap of $330.74 million. The Company’s divisions include Telecom Platform Services, Consumer Phone Services and All Other. It has a 8.64 P/E ratio. The Company’s Telecom Platform Services segment provides retail telecommunications and payment offerings, as well as wholesale international long distance traffic termination.
Since October 17, 2016, it had 0 insider purchases, and 9 sales for $1.74 million activity. $351,108 worth of IDT Corporation (NYSE:IDT) was sold by JONAS HOWARD S on Monday, October 17. 10,222 shares were sold by PEREIRA BILL, worth $189,579 on Friday, December 16. $80,452 worth of stock was sold by MASON JOYCE J on Tuesday, October 18. COSENTINO ERIC F. also sold $15,765 worth of IDT Corporation (NYSE:IDT) shares. The insider FISCHER MARCELO sold $44,455.
Analysts await IDT Corporation (NYSE:IDT) to report earnings on June, 1.
About 161,760 shares traded. IDT Corporation (NYSE:IDT) has declined 5.93% since September 7, 2016 and is downtrending. It has underperformed by 13.20% the S&P500.
About 328 shares traded. Cleveland BioLabs, Inc. (NASDAQ:CBLI) has declined 9.47% since September 7, 2016 and is downtrending. It has underperformed by 16.73% the S&P500.
Analysts await Cleveland BioLabs, Inc. (NASDAQ:CBLI) to report earnings on May, 15.
Bank Of America Corp De holds 0% of its portfolio in Cleveland BioLabs, Inc. for 150 shares. Bank Of Montreal Can owns 31 shares or 0% of their US portfolio. Moreover, Blackrock Advisors Llc has 0% invested in the company for 2,800 shares. The California-based Blackrock Fund Advisors has invested 0% in the stock. Deutsche Bank Ag, a Germany-based fund reported 4 shares.
